198 Combination intratumoral treatment with INTASYL™ self-delivering RNAi targeting TIGIT and PD-1/PD-L1 improves tumor control compared to monotherapy in a CT26 model of murine colorectal cancer

• Melissa Maxwell,
• Dingxue Yan,
• James Cardia,
• Simon Fricker,
• Benjamin Cuiffo,
• Andrej Jedinak

Affiliations

Melissa Maxwell

2Phio Pharmaceuticals, Marlborough, MA, USA

Dingxue Yan

2Phio Pharmaceuticals, Marlborough, MA, USA

James Cardia

2Phio Pharmaceuticals, Marlborough, MA, USA

Simon Fricker

2Phio Pharmaceuticals, Marlborough, MA, USA

Benjamin Cuiffo

Phio Pharmaceuticals, Marlborough, MA, USA, n/a

Andrej Jedinak

Phio Pharmaceuticals, Marlborough, MA, USA, n/a